Sexual and reproductive healthcare providers' opinions on expansion of pharmacy-led provision of contraception
| Autor: | Sharon Cameron, Katie Boog, Zhong Eric Chen |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
030219 obstetrics & reproductive medicine Referral business.industry education Pharmacist Obstetrics and Gynecology Pharmacy Safeguarding 03 medical and health sciences 0302 clinical medicine Reproductive Medicine Hormonal contraception Pill Family medicine medicine 030212 general & internal medicine business Contraceptive implant Reproductive health |
| Zdroj: | BMJ sexualreproductive health. |
| ISSN: | 2515-2009 |
| Popis: | IntroductionReduced funding to contraceptive services in the UK is resulting in restricted access for women. Pharmacists are already embedded in sexual and reproductive health (SRH) care in the UK and could provide an alternative way for women to access contraception. The aim of this study was to determine the views of UK contraception providers about community pharmacist-led contraception provision.MethodsAn anonymous questionnaire was distributed to healthcare professionals at two UK SRH events, asking respondents about: (1) the use of patient group directions (PGDs) for pharmacist provision of oral contraception (OC); (2) the sale of OC as a pharmacy medicine or general sales list medicine; (3) the perceived impact of pharmacy provision of OC on broader SRH outcomes; and (4) if other contraceptive methods should be provided in pharmacies.ResultsOf 240 questionnaires distributed, 174 (72.5%) were returned. Respondents largely supported pharmacy-led provision of all non-uterine methods of contraception, excluding the contraceptive implant. Provision of the progestogen-only pill by PGD was most strongly supported (78% supported initiation). Respondents felt that the use of bridging (temporary) contraception would improve (103/144, 71.5%), use of effective contraception would increase (81/141, 57.4%), and unintended pregnancies would decline (71/130, 54.6%); but that use of long-acting reversible contraception would decrease (86/143, 60.1%). Perceived barriers included pharmacists’ capacity and competency to provide a full contraception consultation, safeguarding concerns, and women having to pay for contraception.ConclusionsUK SRH providers were largely supportive of community pharmacy-led provision of contraception, with training and referral pathways being required to support contraception delivery by pharmacists. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|